Solid Tumors: Immuno-Oncology & Novel Therapeutics

Overcoming Tumor Antigen Heterogeneity in the Context of CAR T Cell therapy for Solid Tumors

Tumor Endothelial Cells in NSCLC: headmasters of tumor immunity

Modeling Therapy-Induced Tumor Cell State Plasticity to Identify Vulnerabilities for Reducing Disease Burden

Cracking open the undruggable RAS: A Clinical Perspective

Development of a novel biodegradable chemo-radioembolic formulation for transarterial treatment of hepatocellular carcinoma

Combination of integrated genomics with ex vivo microcancer drug screens to individualize brain cancer therapy

Age of combination therapy in the treatment of advanced RCC: can we do it better?

Proteomic and N-glycome profiling of secretome from BRAFV600E mutant colon cancer cells with acquired resistance to vemurafenib

Investigating protein- and gene-expression of 27 cytokines/chemokines in melanoma patients. Identification of a 4-genes signature

MET as a druggable target in solid tumors

Flexible samarium-153 radiotherapeutic bandage for radiation therapy of skin cancer

Ion channel drugs as electroceuticals for reprogramming cancer: exploiting bioelectric controls of cell and tissue function

Two retrospective studies on gender differences: chemotherapy toxicities in patients affected by colorectal and pancreatic cancers

Designing a Multi-Epitope Vaccine Against Cancer-Testis Antigens in Non-Small Cell Lung Cancer: an In Silico Approach

Advanced ovarian cancer: exploiting exosomes to potentiate the anti-cancer immune response

Imaging of tumor acidosis for monitoring response to novel anticancer therapies

Solid Tumors: Immuno-Oncology

Cancer therapy potential: molecular characterization of Lucilia sericata angiopoietin-1 | Poster Talk

Apocrine breast carcinoma from biomarkers to therapy

Associating Transcriptomics Data with Inflammatory Markers to Understand Tumour Microenvironment in Hepatocellular Carcinoma